57. 特発性拡張型心筋症 Idiopathic dilated cardiomyopathy Clinical trials / Disease details
臨床試験数 : 11 / 薬物数 : 23 - (DrugBank : 12) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 35
Showing 1 to 10 of 11 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02987322 (ClinicalTrials.gov) | November 2015 | 29/11/2016 | Honey in Idiopathic Dilated Cardiomyopathy | Honey Supplementation in Children With Idiopathic Dilated Cardiomyopathy: A Randomized Controlled Study Honey Supplementation in Children With Idiopathic Dilated Cardiomyopathy: A Randomized Controlled St ... | Idiopathic Dilated Cardiomyopathy | Dietary Supplement: honey | mamdouh abdulmaksoud abdulrhman | NULL | Completed | 2 Years | 12 Years | Both | 50 | Phase 2/Phase 3 | NULL |
2 | NCT02033278 (ClinicalTrials.gov) | January 6, 2014 | 9/1/2014 | Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure. Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Func ... | Multicenter Phase IIb Clinical Trial, Double-blind, Randomized, Controlled Placebo for to Assess the Efficacy of Intracoronary Infusion of Autologous Adult Stem Cells Mononuclear Marrow Unexpanded on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure. Multicenter Phase IIb Clinical Trial, Double-blind, Randomized, Controlled Placebo for to Assess the ... | Idiopathic Dilated Cardiomyopathy | Drug: Infusion of autologous mononuclear bone marrow cells;Drug: Placebo infusion | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Iniciativa Andaluza en Terapias Avanzadas | Terminated | 18 Years | 70 Years | All | 27 | Phase 2 | Spain |
3 | NCT02256501 (ClinicalTrials.gov) | June 2013 | 1/10/2014 | Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy | Intracoronary Transplantation of Autologous Bone Marrow Derived Mononuclear Cells (MNC) in Idiopathic Dilated Cardiomyopathy in Pediatric Patients: Clinical Trial Phase I/II Intracoronary Transplantation of Autologous Bone Marrow Derived Mononuclear Cells (MNC) in Idiopathi ... | Cardiomyopathy | Biological: Mono Nuclear Cell (MNC) transplantation | Nasser Aghdami MD., PhD | NULL | Completed | 1 Year | 16 Years | All | 30 | Phase 1/Phase 2 | Iran, Islamic Republic of |
4 | NCT02292043 (ClinicalTrials.gov) | May 2013 | 31/10/2014 | Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathyor Post-myocardial In ... | Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathyor Post-myocardial In ... | Congestive Heart Failure | Drug: HTEA | Harbin Medical University | NULL | Recruiting | 20 Years | 80 Years | Both | 60 | N/A | China |
5 | NCT01219452 (ClinicalTrials.gov) | October 2010 | 12/10/2010 | Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated C ... | Effects of Intramuscular Injection of Umbilical Cord Mesenchymal Stem Cell on the Ventricular Function of Children With Idiopathic Dilated Cardiomyopathy Effects of Intramuscular Injection of Umbilical Cord Mesenchymal Stem Cell on the Ventricular Functi ... | Dilated Cardiomyopathy | Biological: umbilical cord mesenchymal stem cells | Qingdao University | NULL | Not yet recruiting | 1 Year | 14 Years | Both | 30 | Phase 1/Phase 2 | China |
6 | NCT01302171 (ClinicalTrials.gov) | August 2010 | 21/2/2011 | Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy | Randomised Controlled Trial to Compare the Effects of G-CSF (Granocyte™) and Autologous Bone Marrow Progenitor Cells on Quality of Life and Left Ventricular Function in Patients With Idiopathic Dilated Cardiomyopathy Randomised Controlled Trial to Compare the Effects of G-CSF (Granocyte™) and Autologous Bone Marrow ... | Dilated Cardiomyopathy | Drug: granulocyte colony stimulating factor (GCSF);Procedure: bone marrow mononuclear cells | Barts & The London NHS Trust | Royal Brompton & Harefield NHS Foundation Trust;University College London Hospitals | Completed | 18 Years | 80 Years | Both | 60 | Phase 2 | United Kingdom |
7 | EUCTR2009-013112-12-GB (EUCTR) | 22/04/2010 | 17/03/2010 | Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dilated Cardiomyopathy - REGENERATE-DCM Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow P ... | Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dilated Cardiomyopathy - REGENERATE-DCM Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow P ... | Idiopathic Dilated Cardiomyopathy Level: LLTClassification code 10056419Term: Dilated Cardiomyopathy Idiopathic Dilated Cardiomyopathy Level: LLTClassification code 10056419Term: Dilated Cardiomyopathy ... | Trade Name: Granocyte Lenograstim Product Name: GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF) Product Code: PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION) Trade Name: Granocyte Lenograstim Product Name: GRANOCYTE- 34 million IU (Lenograstim rHuG-CSF) Produc ... | Barts & the London NHS Trust | NULL | Not Recruiting | Female: yes Male: yes | United Kingdom | ||||
8 | NCT02115581 (ClinicalTrials.gov) | September 2006 | 22/12/2008 | Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy | Effect of Coenzyme Q10 (Ubiquinone) Supplementation on Ventricular Function of Children With Idiopathic Dilated Cardiomyopathy.A Randomised Clinical Trial Effect of Coenzyme Q10 (Ubiquinone) Supplementation on Ventricular Function of Children With Idiopat ... | Dilated Cardiomyopathy | Drug: Coenzyme Q10;Drug: Placebo | University of Tehran | NULL | Completed | 6 Months | 18 Years | All | 38 | Phase 4 | Iran, Islamic Republic of |
9 | NCT01917149 (ClinicalTrials.gov) | March 2005 | 30/7/2013 | Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy | Efficacy and Safety Study of Supramaximal Titrated Inhibition of RAAS in Idiopathic Dilated Cardiomyopathy Efficacy and Safety Study of Supramaximal Titrated Inhibition of RAAS in Idiopathic Dilated Cardiomy ... | Dilated Cardiomyopathy | Drug: Benazepril;Drug: Valsartan;Drug: Metoprolol | Xijing Hospital | NULL | Completed | 18 Years | 70 Years | Both | 480 | Phase 4 | China |
10 | NCT00281255 (ClinicalTrials.gov) | June 2003 | 20/1/2006 | Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy | Allopurinol and Cardiac Function Pilot Study in Idiopathic Dilated Cardiomyopathy | Cardiovascular Diseases;Cardiomyopathy, Dilated;Heart Diseases;Heart Failure, Congestive | Drug: Allopurinol;Drug: Dobutamine | University of Pennsylvania | National Heart, Lung, and Blood Institute (NHLBI) | Withdrawn | 18 Years | N/A | Both | 0 | Phase 1/Phase 2 | United States |